Table 2.
Type I error rates for the unadjusted (R) and survival-adjusted (R*) range-based tests by tumor rate (π), shape of the incidence curve (γ1), number of historical control groups (k), and absence/presence of extra variation. All tests were based on a sample size of n=50 per group, with 70% of the animals (on average) surviving to the terminal sacrifice.
| πa | γ1 | No extra variationb |
Extra variationb |
||||
|---|---|---|---|---|---|---|---|
| k=2 | k=5 | k=10 | k=2 | k=5 | k=10 | ||
| Unadjusted range-based test (R) | |||||||
| 0.01 | 1.5 | 27.9 | 9.0 | 4.4 | 30.2 | 9.6 | 4.6 |
| 3.0 | 27.9 | 9.0 | 4.3 | 30.1 | 9.4 | 4.8 | |
| 6.0 | 28.6 | 8.8 | 5.1 | 31.0 | 9.7 | 4.6 | |
| 0.05 | 1.5 | 48.7 | 20.9 | 11.0 | 49.6 | 22.0 | 11.5 |
| 3.0 | 48.4 | 21.0 | 11.0 | 49.6 | 21.7 | 11.7 | |
| 6.0 | 49.2 | 20.8 | 11.2 | 50.0 | 21.5 | 11.4 | |
| 0.15 | 1.5 | 55.9 | 26.0 | 13.1 | 56.1 | 25.8 | 13.6 |
| 3.0 | 56.1 | 26.3 | 13.1 | 56.3 | 26.1 | 13.4 | |
| 6.0 | 56.1 | 26.2 | 13.0 | 56.1 | 26.5 | 13.6 | |
| 0.30 | 1.5 | 57.7 | 26.5 | 14.0 | 58.1 | 26.7 | 14.1 |
| 3.0 | 58.1 | 27.2 | 14.0 | 58.7 | 27.1 | 14.1 | |
| 6.0 | 58.7 | 26.7 | 13.8 | 58.5 | 26.9 | 14.5 | |
| Poly-3 survival-adjusted range-based test (R*) | |||||||
| 0.01 | 1.5 | 36.9 | 16.4 | 9.1 | 40.4 | 16.8 | 8.8 |
| 3.0 | 37.0 | 16.4 | 9.1 | 39.9 | 16.7 | 9.2 | |
| 6.0 | 38.0 | 16.3 | 9.9 | 41.4 | 17.3 | 9.1 | |
| 0.05 | 1.5 | 65.6 | 31.5 | 17.1 | 66.2 | 32.6 | 18.4 |
| 3.0 | 65.8 | 31.8 | 17.4 | 66.1 | 32.3 | 18.5 | |
| 6.0 | 65.9 | 31.9 | 17.2 | 66.2 | 32.4 | 17.8 | |
| 0.15 | 1.5 | 67.0 | 34.0 | 18.2 | 66.3 | 33.7 | 18.2 |
| 3.0 | 67.0 | 34.0 | 17.9 | 66.6 | 33.8 | 18.1 | |
| 6.0 | 66.7 | 33.8 | 17.9 | 66.6 | 33.8 | 18.4 | |
| 0.30 | 1.5 | 65.9 | 33.2 | 18.2 | 66.1 | 32.6 | 17.8 |
| 3.0 | 66.2 | 32.9 | 17.9 | 66.5 | 33.3 | 17.7 | |
| 6.0 | 66.5 | 32.9 | 17.5 | 66.8 | 33.2 | 18.3 | |
The mean tumor rate among the historical control groups (πh) equals the mean tumor rate in the current control group (πc) under the null hypothesis (H0: πh = πc = π).
The variance of the tumor rates among the historical control groups in the presence of extra variation is 20% larger than in the absence of extra variation.